Midterm Outcomes of Early Versus Late Surgery for Infective Endocarditis with Neurologic Complications: A Meta-analysis

doi:10.21203/rs.3.rs-94760/v1

Download PDF

Research article

Midterm Outcomes of Early Versus Late Surgery for Infective Endocarditis with Neurologic Complications: A Meta-analysis

https://doi.org/10.21203/rs.3.rs-94760/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 25 Mar, 2021

Read the published version in Journal of Cardiothoracic Surgery →

You are reading this latest preprint version

Background: Cerebral infarction (CI) remains one of the most common and fatal complications of infective endocarditis (IE), and the timing of surgery for IE with neurologic complications is controversial. As outcomes beyond the perioperative period have not been assessed with a meta-analysis previously, we conducted a meta-analysis comparing mid- to long-term outcomes of early and late surgery in patients with IE and neurologic complications.

Methods: All studies that investigated early and late surgery in patients with IE and neurologic complications were identified. The primary and secondary endpoints were all-cause mortality and recurrence, respectively. Hazard ratios (HRs) for all-cause mortality and recurrence were extracted from each study.

Results: Our search identified five eligible studies, which were all observational studies consisting of a total of 624 patients with IE and neurologic complications. Pooled analyses demonstrated that all-cause mortality was similar between the early and late surgery groups (HR [95% confidence interval [CI]]=0.90 [0.49-1.64]; P=0.10; I²=49%). Similarly, the recurrence rates were similar between both groups (HR [95% CI]=1.86 [0.76-4.52]; P=0.43; I²=0%).

Conclusions: Our meta-analysis showed similar mortality and recurrent rates between the early and late surgery groups. The optimal timing of surgery should be individualized on a case-to-case basis.

Cardiac & Cardiovascular Systems

infective endocarditis

early surgery

neurologic complication

stroke

cerebral infarction

Cerebral infarction (CI) is still one of the most common and fatal complications of infective endocarditis (IE). The incidence of CI varies from 10–40% [1, 2], with an increased risk of mortality [3, 4]. The timing of surgery for IE with neurologic complications remains controversial since early surgery might result in conversion into hemorrhagic stroke as a result of systemic anticoagulation during cardiopulmonary bypass, or the exacerbation of an ischemic stroke from hypotension during surgery, although late surgery might result in continued neurological insult from embolic events. A previous meta-analysis showed that early surgery was associated with a significant increase in perioperative mortality and neurological deterioration in patients with IE complicated with neurologic events [5]. However, the outcomes beyond the perioperative period were not analyzed as many studies did not investigate long-term outcomes or just provided Kaplan-Meier curves without hazard ratios [HRs]. We previously reported a method to extract HRs from Kaplan-Meier curves [6]. By using this method and updating the available studies, we conducted a meta-analysis comparing mid- to long-term outcomes of early and late surgery in patients with IE complicated with neurologic events.

All studies that investigated early and late surgery in patients with IE and neurologic complications were identified using a two-level strategy. First, databases including MEDLINE and EMBASE were searched on July 27, 2020, using Web-based search engines (PubMed and OVID). Second, relevant studies were identified through a manual search of secondary sources, including references of initially identified articles, reviews, and commentaries. All references were downloaded for consolidation, elimination of duplicates, and further analyses. Search terms included “endocarditis,” “early or timing,” and “surgery or surgical.” We did not apply language limitations. Two independent and blinded authors (Y.Y. and T.G.) reviewed the search results separately to select the studies based on present inclusion and exclusion criteria. Disagreements were resolved by means of a consensus-based discussion.

The included studies met the following criteria: the study was a randomized controlled trial or an observational study, the study population consisted of patients with IE and neurologic complications including CI or intracranial hemorrhage, the enrolled patients were assigned to the early surgery group and the late surgery group, and the outcomes included all-cause mortality with more than 6 months of follow-up. The definitions of early and late surgery were according to each study.

The primary endpoint was all-cause mortality, and the secondary endpoint was recurrence. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement standards [7]. HRs for all-cause mortality and recurrence were extracted from each study. The adjusted HR was extracted if available. If the HR was not described in a study, then the HR was calculated from the Kaplan-Meier curve if available using the “HR-calculation spreadsheet” developed by Tierney et al. [8] based on standard statistical methods reported by Palmar et al. [9] and Williamson et al. [10]. If a Kaplan-Meier curve was not provided in a study, then the risk ratio was calculated from the event number and the patient number. Review Manager (RevMan) Version 5.3 (Nordic Cochrane Centre, the Cochrane Collaboration, 2012, Copenhagen, Denmark) was used to combine HRs in the random-effects model. The random-effects model was used in each outcome regardless of the heterogeneity among studies as it allowed for a more conservative assessment of the pooled effect size. ProMeta 3 software (https://idostatistics.com/prometa3/) was used to perform sensitivity analyses and examine funnel-plot asymmetry. Funnel-plot asymmetry suggesting publication bias was assessed mathematically using Egger’s linear-regression test [11]. Significant heterogeneity was considered to be present when the I² index was over 50% or the P for heterogeneity was < .05. Sensitivity analyses were performed by eliminating one study at a time to confirm that our findings were not derived from any single study [12].

Our search identified five eligible studies [13–17], which were all observational studies consisting of a total of 624 patients with IE complicated with neurologic events assigned to the early surgery (n = 252) or late surgery groups (n = 372) (Fig. 1). The study profile and patient characteristics are summarized in Table 1.

Table 1

Summary of included studies.
Author	Year	Follow-up (months)		Definition of early surgery			Mean or median time to surgery (day)					Patients (n)			Early (n)				Late (n)
				Early			Early				Late
Thuny [13]	2009	6		<7 days			3			19			241			95		146
Kim [14]	2011	62		<14 days			3			20			56			34		22
Barsic [15]	2012	12		<7 days			NA			NA			56			34		22
Oh [16]	2016	51		<7 days			4			17			39			20		19
Samura [17]	2019	60		< 3days			1			16			90			45		45
Age, median or mean ± SD			Female (%)			Diabetes (%)							CHF (%)
Early	Late		Early		Late	Early			Late				Early				Late
53 ± 16	58 ± 15		27		21	10			15				46				40
44 ± 14	40 ± 16		32		36	9			14				NA				NA
53	57		31		32	24			17				NA				NA
53 ± 15	45 ± 15		25		42	10			5				50				42
64	65		44		36	24			36				NA				NA
Valve involved								Prosthetic valve (%)						Cerebral hemorrhage (%)
Early			Late					Early		Late				Early				Late
A-64%, M-53%, B-19%			M-70%, B-50%, T-22%					21		31				2				5
A-35%, M-53%, B-12%			A-27%, M-55%, B-18%					3		27				14				41
A-60%, M-43%			A-48%, M-58%					22		23				NA				NA
A-55%, M-55%, T-5%			A-47%, M-79%					45		37				20				32
A-45%, M-71%			A-45%, M-64%					19		21				0				0

A=aortic valve, B-aortic and mitral valves, CHF=congestive heart failure, M-mitral valve, NA=not available, T=tricuspid valve

Pooled analyses demonstrated that all-cause mortality was similar between the early and late surgery groups (HR [95% confidence interval [CI]] = 0.90 [0.49–1.64]; P = 0.10; I² = 49%) (Fig. 2A). Likewise, the recurrence rates were similar in both groups (HR [95% CI] = 1.86 [0.76–4.52]; P = 0.43; I² = 0%) (Fig. 2B).

Publication bias was assessed using funnel plots (Fig. 3), which showed no evidence of publication bias in the analyses of all-cause mortality and recurrence, respectively (P = 0.75, 0.51). In terms of sensitivity analyses (Fig. 4), eliminating any single study did not change the primary results (pooling all the studies) of both all-cause mortality and recurrence.

This meta-analysis demonstrated that early and late surgery in patients with IE complicated with CI were associated with similar rates of all-cause mortality and recurrence. IE remains a major illness with a high mortality secondary to complications including congestive heart failure and neurologic events [18, 19]. Current guidelines recommend early surgery when specific parameters are met, such as recurrent emboli or large vegetation [20, 21]. A previous meta-analysis demonstrated that early surgery was associated with significant reduction in all-cause mortality in patients with IE [22]. However, early surgery might have an opposite effect after IE is complicated with neurologic events, since anticoagulation during cardiopulmonary bypass can turn an ischemic stroke into a hemorrhagic stroke, or exacerbate a stroke due to hypotension during operation. Current guidelines recommend delaying surgery for 3 to 4 weeks in IE patients with major or hemorrhagic stroke [23, 24]. Similarly, a recent meta-analysis showed that early surgery was associated with increased mortality and neurological exacerbation in patients with hemorrhagic stroke as well as ischemic stroke [5]. However, they were unable to analyze the outcomes beyond the perioperative period owing to scarcity of data on mid- to long-term outcomes.

This is the first meta-analysis comparing the outcomes beyond the perioperative period between early and late surgery in patients with IE complicated with CI. Although previous meta-analyses demonstrated worse perioperative mortality with early surgery than that with late surgery [5, 22], our results showed similar mortality and recurrence rates. Furthermore, leave-one-out sensitivity analysis showed that eliminating any one of those studies did not change the outcomes, suggesting that our findings were not derived from any single study. This could be attributed the fact that 40–60% of patients with IE develop heart failure because of structural damage [25, 26], and early surgery might prevent the development of heart failure caused by progressive regurgitation [27]. Therefore, although early surgery might increase preoperative mortality and neurologic complications in patients with IE complicated with neurologic events [5], it might have a positive effect on long-term outcomes by preserving cardiac function.

Our analysis has several limitations. First, our study comprised observational studies and is therefore subject to possible selection bias. Second, we did not analyze perioperative outcomes, since a previous meta-analysis including 27 observational studies [5] was conducted and the perioperative outcomes were thoroughly analyzed. Although they could not analyze the outcomes beyond the perioperative period, we were able to analyze them by extracting the HR from the Kaplan-Meier curve [6]. Third, the definition of early surgery varied among the studies, ranging from 3 to 14 days. Finally, there might be survivor bias in the late surgery group, and we could not assess how many patients died while waiting for the surgery.

Our meta-analysis showed similar mortality and recurrent rates between early and late surgery in patients with IE complicated with neurologic events. The optimal timing of surgery should be individualized on a case-to-case basis. Further trials with long-term outcomes are warranted.

CI: cerebral infarction,

IE: infective endocarditis,

HR: Hazard ratio

Acknowledgments

None.

Author’s contributions

YY wrote the paper. YY and TG collected data. TG reviewed the paper. The authors read and approved the final manuscript.

Funding

None.

Availability of data and materials

Not applicable.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

None.

Snygg-Martin U, Gustafsson L, Rosengren, L, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23-30.

Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112:69-75.

Ruttmann E, Willeit J, Ulmer H, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37:2094-9.
Anderson DJ, Goldstein LB, Wilkinson WE, et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003;61:1341–1346.
Tam DY, Yanagawa B, Verma S, et al. Early vs Late Surgery for Patients With Endocarditis and Neurological Injury: A Systematic Review and Meta-analysis. Can J Cardiol. 2018;34:1185-1199.
Yokoyama Y, Kuno T, Takagi H. Meta-analysis of phase-specific survival after elective endovascular versus surgical repair of abdominal aortic aneurysm from randomized controlled trials and propensity score-matched studies [published online ahead of print, 2020 Apr 21]. J Vasc Surg. 2020;S0741-5214(20)30595-4.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94

Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis, Trials 8 (2007) 16.

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints, Stat. Med. 17 (1998) 2815–2834.

Williamson PR, Smith CT, Hutton JL, et al. Aggregate data meta-analysis with time-to-event outcomes, Stat. Med. 21 (2002) 3337–3351.

Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. 1997;315:629-6349310563.

Wang ZY, Zhao K, Zheng J, et al. Systematic review and meta-analysis of the association between complement factor H I62V polymorphism and risk of polypoidal choroidal vasculopathy in Asian populations. PLoS One. 2014 Feb 10;9(2):e88324.

Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32(16):2027-33.

Kim GS, Kim JB, Jung SH, et al. Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Early versus Delayed Surgery. Korean J Thorac Cardiovasc Surg. 2011;44:332-7.

Barsic B, Dickerman S, Krajinovic V, et al. International Collaboration on Endocarditis–Prospective Cohort Study Investigators. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013;56:209-17.

Oh TH, Wang TK, Pemberton JA, et al. Early or late surgery for endocarditis with neurological complications. Asian Cardiovasc Thorac Ann. 2016;24:435-40.

Samura T, Yoshioka D, Toda K, et al. Emergency valve surgery improves clinical results in patients with infective endocarditis complicated with acute cerebral infarction: analysis using propensity score matching†. Eur J Cardiothorac Surg. 2019;56:942-949.

Thuny F, Grisoli D, Collart F, et al. Management of infective endocarditis: challenges and perspectives. Lancet, 2012;379: 965–975.
Bashore TM, Cabell C, Fowler V Jr. Update on infective endocarditis. Curr Probl Cardiol. 2006;31:274-352.
Winston LG, Bolger AF. Modern epidemiology, prophylaxis, and diagnosis and therapy for infective endocarditis. Curr Cardiol Rep. 2006;8(2):102-108.
Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91:571-575.
Jia L, Wang Z, Fu Q, et al. Could Early Surgery Get Beneficial in Adult Patients with Active Native Infective Endocarditis? A Meta-Analysis. Biomed Res Int. 2017;2017:3459468.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-86.
Fukuda W, Daitoku K, Minakawa M, et al. Infective endocarditis with cerebrovascular complications: timing of surgical intervention. Interact Cardiovasc Thorac Surg 2012;14:26-30.
Nadji G, Rusinaru D, Rémadi JP, et al. Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail. 2009;11:668-675.
Revilla A, López J, Vilacosta I, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J. 2007;28:65-71.
Funakoshi S, Kaji S, Yamamuro A, et al. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg. 2011;142:836-842.

Download PDF

Journal Publication

published 25 Mar, 2021

Read the published version in Journal of Cardiothoracic Surgery →

Editorial decision: Accept
08 Mar, 2021
Review #3 received at journal
15 Jan, 2021
Review #2 received at journal
15 Jan, 2021
Reviewer #3 agreed at journal
08 Jan, 2021
Reviewer #2 agreed at journal
18 Nov, 2020
Review #1 received at journal
09 Nov, 2020
Reviewers invited by journal
31 Oct, 2020
Reviewer #1 agreed at journal
31 Oct, 2020
First submitted to journal
18 Oct, 2020
Editor assigned by journal
18 Oct, 2020
Submission checks completed at journal
17 Oct, 2020
Editor invited by journal
17 Oct, 2020

You are reading this latest preprint version

Midterm Outcomes of Early Versus Late Surgery for Infective Endocarditis with Neurologic Complications: A Meta-analysis

Status:

Journal Publication

Version 1

Abstract

Figures

Background

Methods

Results

Discussion

Conclusions

Abbreviations

Declarations

Acknowledgments

Author’s contributions

Funding

Availability of data and materials

Ethics approval and consent to participate

Consent for publication

Competing interests

References

Status:

Journal Publication

Version 1